Uveitis

Uveitis is an inflammatory condition affecting the uveal tract, including the iris, ciliary body, and choroid, and it may extend to adjacent ocular tissues such as the retina and vitreous. As a major topic at a global Ophthalmology Conference, uveitis research addresses complex immune-mediated mechanisms, infectious causes, and long-term management strategies aimed at preserving vision. Because untreated or recurrent inflammation can lead to glaucoma, cataract, macular edema, or permanent intraocular inflammation, early diagnosis and targeted therapy are essential.

Uveitis may be classified anatomically as anterior, intermediate, posterior, or panuveitis depending on the primary site of inflammation. Etiology varies widely and includes autoimmune disorders, systemic inflammatory diseases, infectious pathogens, and idiopathic origins. Conditions such as sarcoidosis, juvenile idiopathic arthritis, ankylosing spondylitis, tuberculosis, and viral infections are commonly associated systemic contributors.

Comprehensive evaluation includes slit-lamp biomicroscopy, dilated fundus examination, optical coherence tomography, fluorescein angiography, and laboratory investigations to identify underlying causes. Multidisciplinary collaboration with rheumatologists and infectious disease specialists is often required for systemic assessment and management.

Treatment strategies focus on controlling inflammation and preventing recurrence. Topical, periocular, or systemic corticosteroids are frequently used for acute episodes. Immunomodulatory therapy and biologic agents provide long-term control in chronic or refractory cases. Anti-infective therapy is essential when an infectious etiology is confirmed. Careful monitoring is necessary to avoid complications associated with prolonged steroid use.

Advances in targeted biologic therapies have significantly improved outcomes in autoimmune-related uveitis. Sustained-release intraocular implants offer long-term inflammation control with reduced systemic exposure. Research continues to explore molecular biomarkers for disease activity and personalized therapeutic approaches.

By integrating immunology, infectious disease expertise, and advanced imaging, uveitis management continues to evolve toward precision care and improved long-term visual preservation.